RSS0393 ointment
Sponsors
Jiangsu HengRui Medicine Co., Ltd., Reistone Biopharma Company Limited
Conditions
Atopic Dermatitis of AdultsPlaque Psoriasis in AdolescentsPlaque Psoriasis in ChildrenPsoriatic Subjects
Phase 2
To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study
Not yet recruitingNCT06918743
Start: 2025-04-30End: 2026-03-31Target: 147Updated: 2025-04-09
A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis
Not yet recruitingNCT07102888
Start: 2025-08-31End: 2026-02-28Target: 20Updated: 2025-08-05
A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
CompletedNCT07158151
Start: 2025-09-25End: 2026-04-10Updated: 2026-04-29